Cullinan Therapeutics, Inc. Common Stock CGEM
$16.87
-22.15%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $35.00
- Implied Upside
- +107.5%
- Price Target Range
- $30.00 – $42.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-14 | BTIGJulian Harrison |
Maintains | Buy | $39 → $40 |
| 2026-08-17 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $30 |
| 2026-08-13 | WedbushRobert Driscoll |
Maintains | Outperform | $39 → $42 |
| 2026-07-29 | BTIGJulian Harrison |
Maintains | Buy | $38 → $39 |
| 2026-06-11 | WedbushRobert Driscoll |
Reiterates | Outperform | $37 |
| 2026-06-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $30 |
| 2026-05-19 | BTIGJulian Harrison |
Reiterates | Buy | $38 |
| 2026-05-08 | WedbushRobert Driscoll |
Maintains | Outperform | $36 → $37 |
| 2026-05-04 | BTIGJulian Harrison |
Reiterates | Buy | $38 |
| 2026-04-28 | BTIGJulian Harrison |
Reiterates | Buy | $38 |
| 2026-04-28 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $27 → $30 |
| 2026-03-11 | WedbushRobert Driscoll |
Maintains | Outperform | $34 → $36 |
| 2026-02-17 | CitigroupSamantha Semenkow |
Initiates coverage on | Buy | $33 |
| 2026-02-02 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $30 |
| 2026-01-08 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $26 → $27 |
| 2025-12-09 | WedbushRobert Driscoll |
Maintains | Outperform | $25 → $34 |
| 2025-11-24 | BTIGJulian Harrison |
Maintains | Buy | $32 → $38 |
| 2025-11-20 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $24 → $26 |
| 2025-09-12 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $24 |
| 2025-09-10 | BTIGJulian Harrison |
Reiterates | Buy | $32 |
| 2025-08-21 | HC Wainwright & Co.Robert Burns |
Assumes | Buy | $24 |
| 2025-08-18 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $35 → $28 |
| 2025-06-11 | StifelAlex Thompson |
Reinstates | Buy | $22 |
| 2025-05-12 | UBSDavid Dai |
Maintains | Buy | $30 → $24 |
| 2025-04-16 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $33 |
| 2025-03-07 | Morgan StanleyJeffrey Hung |
Assumes | Overweight | $38 → $35 |
| 2025-02-28 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $33 |
| 2025-01-29 | HC Wainwright & Co.Edward White |
Maintains | Buy | $28 → $33 |
| 2024-10-24 | UBSDavid Dai |
Initiates coverage on | Buy | $30 |
| 2024-10-16 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $28 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.87
- Market Cap
- $1.39 billion
- 52-Week Range
- $5.68 – $23.19
- Average Volume
- 951K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.